A detailed history of Mbm Wealth Consultants, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Mbm Wealth Consultants, LLC holds 2,110 shares of UTHR stock, worth $766,457. This represents 0.25% of its overall portfolio holdings.

Number of Shares
2,110
Previous 1,982 6.46%
Holding current value
$766,457
Previous $631,000 19.81%
% of portfolio
0.25%
Previous 0.22%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

BUY
$311.04 - $363.55 $39,813 - $46,534
128 Added 6.46%
2,110 $756,000
Q2 2024

Jul 30, 2024

SELL
$228.26 - $319.04 $59,119 - $82,631
-259 Reduced 11.56%
1,982 $631,000
Q1 2024

Apr 18, 2024

BUY
$210.76 - $249.51 $12,434 - $14,721
59 Added 2.7%
2,241 $514,000
Q4 2023

Jan 30, 2024

BUY
$214.88 - $256.94 $468,868 - $560,643
2,182 New
2,182 $479,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.5B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Mbm Wealth Consultants, LLC Portfolio

Follow Mbm Wealth Consultants, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mbm Wealth Consultants, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mbm Wealth Consultants, LLC with notifications on news.